{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:41:50Z","timestamp":1794883310651,"version":"4.9.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K22NS092688"],"award-info":[{"award-number":["K22NS092688"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1R01AG059639"],"award-info":[{"award-number":["1R01AG059639"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","award":["AARGD-591887"],"award-info":[{"award-number":["AARGD-591887"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0680-z","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T11:38:32Z","timestamp":1551181112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy"],"prefix":"10.1186","volume":"7","author":[{"given":"Yingjian","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Cisternas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braulio","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly J.","family":"Garringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian L.","family":"Oblak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady K.","family":"Atwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian A.","family":"Lasagna-Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"key":"680_CR1","doi-asserted-by":"publisher","unstructured":"Andrews-Zwilling Y, Bien-Ly N, Xu Qet al. (2010) Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J Neurosci 30:13707\u201313717 \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4040-10.2010","DOI":"10.1523\/JNEUROSCI.4040-10.2010"},{"key":"680_CR2","doi-asserted-by":"publisher","unstructured":"Asai H, Ikezu S, Tsunoda Set al. (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18:1584\u20131593 \n                    https:\/\/doi.org\/10.1038\/nn.4132","DOI":"10.1038\/nn.4132"},{"key":"680_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J (2005) Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 110:345\u2013359. \n                    https:\/\/doi.org\/10.1007\/s00401-005-1074-9","journal-title":"Acta Neuropathol"},{"key":"680_CR4","doi-asserted-by":"publisher","unstructured":"Bartels AL, Willemsen AT, Kortekaas ret al. (2008) decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. J Neural Transm (Vienna) 115:1001\u20131009 \n                    https:\/\/doi.org\/10.1007\/s00702-008-0030-y","DOI":"10.1007\/s00702-008-0030-y"},{"key":"680_CR5","doi-asserted-by":"publisher","first-page":"E1289","DOI":"10.1073\/pnas.1710329115","volume":"115","author":"RE Bennett","year":"2018","unstructured":"Bennett RE, Robbins AB, Hu M et al (2018) Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A 115:E1289\u2013E1298. \n                    https:\/\/doi.org\/10.1073\/pnas.1710329115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"680_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","volume":"7","author":"A Biffi","year":"2011","unstructured":"Biffi A, Greenberg SM (2011) Cerebral amyloid angiopathy: a systematic review. J Clin Neurol 7:1\u20139. \n                    https:\/\/doi.org\/10.3988\/jcn.2011.7.1.1","journal-title":"J Clin Neurol"},{"key":"680_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40478-015-0186-2","volume":"3","author":"LJ Blair","year":"2015","unstructured":"Blair LJ, Frauen HD, Zhang B et al (2015) Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. Acta Neuropathol Commun 3:8. \n                    https:\/\/doi.org\/10.1186\/s40478-015-0186-2","journal-title":"Acta Neuropathol Commun"},{"key":"680_CR8","doi-asserted-by":"publisher","unstructured":"Bloom GS (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71:505\u2013508. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2013.5847","DOI":"10.1001\/jamaneurol.2013.5847"},{"key":"680_CR9","doi-asserted-by":"publisher","unstructured":"Boulouis G, Charidimou A, Greenberg SM (2016) Sporadic Cerebral Amyloid Angiopathy: Pathophysiology, Neuroimaging Features, and Clinical Implications. Semin Neurol 36: 233\u2013243. \n                    https:\/\/doi.org\/10.1055\/s-0036-1581993","DOI":"10.1055\/s-0036-1581993"},{"key":"680_CR10","doi-asserted-by":"publisher","unstructured":"Castillo-Carranza DL, Nilson AN, Van Skike CE et al (2017) Cerebral microvascular accumulation of tau oligomers in Alzheimer's disease and related Tauopathies. Aging Dis 8:257\u2013266. \n                    https:\/\/doi.org\/10.14336\/AD.2017.0112","DOI":"10.14336\/AD.2017.0112"},{"key":"680_CR11","doi-asserted-by":"publisher","unstructured":"Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ et al (2014) Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci 34:4260\u20134272. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3192-13.2014","DOI":"10.1523\/JNEUROSCI.3192-13.2014"},{"key":"680_CR12","doi-asserted-by":"publisher","unstructured":"Charidimou A, Martinez-Ramirez S, Shoamanesh Aet al. (2015) Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes. Neurology 84: 1206\u20131212. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000001398","DOI":"10.1212\/WNL.0000000000001398"},{"key":"680_CR13","doi-asserted-by":"publisher","first-page":"e115765","DOI":"10.1371\/journal.pone.0115765","volume":"9","author":"JS Cheng","year":"2014","unstructured":"Cheng JS, Craft R, Yu GQ et al (2014) Tau reduction diminishes spatial learning and memory deficits after mild repetitive traumatic brain injury in mice. PLoS One 9:e115765. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0115765","journal-title":"PLoS One"},{"key":"680_CR14","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1007\/s12035-015-9609-0","volume":"53","author":"P Cisternas","year":"2016","unstructured":"Cisternas P, Louveau A, Bueno SM, Kalergis AM, Boudin H, Riedel CA (2016) Gestational hypothyroxinemia affects glutamatergic synaptic protein distribution and neuronal plasticity through neuron-astrocyte interplay. Mol Neurobiol 53:7158\u20137169. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9609-0","journal-title":"Mol Neurobiol"},{"key":"680_CR15","doi-asserted-by":"publisher","unstructured":"Citron M (2010) Alzheimer's disease: strategies for disease modification. Nat Rev Drug Discov 9: 387\u2013398. \n                    https:\/\/doi.org\/10.1038\/nrd2896","DOI":"10.1038\/nrd2896"},{"key":"680_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ncomms1255","volume":"2","author":"TJ Cohen","year":"2011","unstructured":"Cohen TJ, Guo JL, Hurtado DE et al (2011) The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat Commun 2:252. \n                    https:\/\/doi.org\/10.1038\/ncomms1255","journal-title":"Nat Commun"},{"key":"680_CR17","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1523\/JNEUROSCI.3861-05.2006","volume":"26","author":"DV Dabir","year":"2006","unstructured":"Dabir DV, Robinson MB, Swanson E et al (2006) Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J Neurosci 26:644\u2013654. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3861-05.2006","journal-title":"J Neurosci"},{"key":"680_CR18","doi-asserted-by":"publisher","unstructured":"de la Chapelle A, Tolvanen R, Boysen Get al. (1992) Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 2:157\u2013160 \n                    https:\/\/doi.org\/10.1038\/ng1092-157","DOI":"10.1038\/ng1092-157"},{"key":"680_CR19","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","volume":"33","author":"SL DeVos","year":"2013","unstructured":"DeVos SL, Goncharoff DK, Chen G et al (2013) Antisense reduction of tau in adult mice protects against seizures. J Neurosci 33:12887\u201312897. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2107-13.2013","journal-title":"J Neurosci"},{"key":"680_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nm.3617","volume":"20","author":"M Fernandez-Nogales","year":"2014","unstructured":"Fernandez-Nogales M, Cabrera JR, Santos-Galindo M et al (2014) Huntington's disease is a four-repeat tauopathy with tau nuclear rods. Nat Med 20:881\u2013885. \n                    https:\/\/doi.org\/10.1038\/nm.3617","journal-title":"Nat Med"},{"key":"680_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/NEN.0000000000000180","volume":"74","author":"I Ferrer","year":"2015","unstructured":"Ferrer I, Legati A, Garcia-Monco JC et al (2015) Familial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathy. J Neuropathol Exp Neurol 74:370\u2013379. \n                    https:\/\/doi.org\/10.1097\/NEN.0000000000000180","journal-title":"J Neuropathol Exp Neurol"},{"key":"680_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00429-009-0221-9","volume":"214","author":"HJ Garringer","year":"2010","unstructured":"Garringer HJ, Murrell J, D'Adamio L, Ghetti B, Vidal R (2010) Modeling familial British and Danish dementia. Brain Struct Funct 214:235\u2013244. \n                    https:\/\/doi.org\/10.1007\/s00429-009-0221-9","journal-title":"Brain Struct Funct"},{"key":"680_CR23","doi-asserted-by":"publisher","first-page":"e56426","DOI":"10.1371\/journal.pone.0056426","volume":"8","author":"HJ Garringer","year":"2013","unstructured":"Garringer HJ, Murrell J, Sammeta N, Gnezda A, Ghetti B, Vidal R (2013) Increased tau phosphorylation and tau truncation, and decreased synaptophysin levels in mutant BRI2\/tau transgenic mice. PLoS One 8:e56426. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0056426","journal-title":"PLoS One"},{"key":"680_CR24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1073\/pnas.93.2.744","volume":"93","author":"B Ghetti","year":"1996","unstructured":"Ghetti B, Piccardo P, Spillantini MG et al (1996) Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A 93:744\u2013748","journal-title":"Proc Natl Acad Sci U S A"},{"key":"680_CR25","doi-asserted-by":"crossref","unstructured":"Ghetti B, Tagliavini F, Masters CL et al (1989) Gerstmann-Straussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 39:1453\u20131461","DOI":"10.1212\/WNL.39.11.1453"},{"key":"680_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ana.24230","volume":"76","author":"AL Gheyara","year":"2014","unstructured":"Gheyara AL, Ponnusamy R, Djukic B et al (2014) Tau reduction prevents disease in a mouse model of Dravet syndrome. Ann Neurol 76:443\u2013456. \n                    https:\/\/doi.org\/10.1002\/ana.24230","journal-title":"Ann Neurol"},{"key":"680_CR27","doi-asserted-by":"publisher","unstructured":"Giaccone G, Mangieri M, Capobianco ret al. (2008) Tauopathy in human and experimental variant Creutzfeldt-Jakob disease. Neurobiol aging 29:1864\u20131873. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.04.026","DOI":"10.1016\/j.neurobiolaging.2007.04.026"},{"key":"680_CR28","doi-asserted-by":"crossref","unstructured":"Giaccone G, Tagliavini F, Verga let al. (1990) neurofibrillary tangles of the Indiana kindred of Gerstmann-Straussler-Scheinker disease share antigenic determinants with those of Alzheimer disease. Brain res 530: 325\u2013329","DOI":"10.1016\/0006-8993(90)91304-Y"},{"key":"680_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","volume":"9","author":"E Giacobini","year":"2013","unstructured":"Giacobini E, Gold G (2013) Alzheimer disease therapy--moving from amyloid-beta to tau. Nat Rev Neurol 9:677\u2013686. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2013.223","journal-title":"Nat Rev Neurol"},{"key":"680_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","volume":"119","author":"GK Gouras","year":"2010","unstructured":"Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E (2010) Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease. Acta Neuropathol 119:523\u2013541. \n                    https:\/\/doi.org\/10.1007\/s00401-010-0679-9","journal-title":"Acta Neuropathol"},{"key":"680_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nbd.2014.08.008","volume":"71","author":"MJ Guerrero-Munoz","year":"2014","unstructured":"Guerrero-Munoz MJ, Castillo-Carranza DL, Krishnamurthy S et al (2014) Amyloid-beta oligomers as a template for secondary amyloidosis in Alzheimer's disease. Neurobiol Dis 71:14\u201323. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2014.08.008","journal-title":"Neurobiol Dis"},{"key":"680_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/35058528","volume":"2","author":"PG Haydon","year":"2001","unstructured":"Haydon PG (2001) GLIA: listening and talking to the synapse. Nat Rev Neurosci 2:185\u2013193. \n                    https:\/\/doi.org\/10.1038\/35058528","journal-title":"Nat Rev Neurosci"},{"key":"680_CR33","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","volume":"33","author":"JK Holth","year":"2013","unstructured":"Holth JK, Bomben VC, Reed JG et al (2013) Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy. J Neurosci 33:1651\u20131659. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3191-12.2013","journal-title":"J Neurosci"},{"key":"680_CR34","doi-asserted-by":"crossref","unstructured":"Holton JL, Lashley T, Ghiso J et al (2002) Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol 61:254\u2013267","DOI":"10.1093\/jnen\/61.3.254"},{"key":"680_CR35","doi-asserted-by":"publisher","unstructured":"Holton JL, Ghiso J, Lashley Tet al. (2001) regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 158:515\u2013526. \n                    https:\/\/doi.org\/10.1016\/S0002-9440(10)63993-4","DOI":"10.1016\/S0002-9440(10)63993-4"},{"key":"680_CR36","doi-asserted-by":"crossref","unstructured":"Ikeda K, Akiyama H, Kondo Het al. (1995) Thorn-shaped astrocytes: possibly secondarily induced tau-positive glial fibrillary tangles. Acta Neuropathol 90:620\u2013625","DOI":"10.1007\/BF00318575"},{"key":"680_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha GA, Bowser R, Kazam IG, Davies P (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128\u2013132","journal-title":"J Neurosci Res"},{"key":"680_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1189\/jlb.1109766","volume":"87","author":"R Jin","year":"2010","unstructured":"Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87:779\u2013789. \n                    https:\/\/doi.org\/10.1189\/jlb.1109766","journal-title":"J Leukoc Biol"},{"key":"680_CR39","doi-asserted-by":"publisher","unstructured":"Karch CM, Cruchaga C, Goate AM (2014) Alzheimer's disease genetics: from the bench to the clinic. Neuron 83:11\u201326. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2014.05.041","DOI":"10.1016\/j.neuron.2014.05.041"},{"key":"680_CR40","doi-asserted-by":"publisher","unstructured":"Kim HJ, Park S, Cho H et al (2018) Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging. JAMA Neurol. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2018.0975","DOI":"10.1001\/jamaneurol.2018.0975"},{"key":"680_CR41","doi-asserted-by":"crossref","unstructured":"Komori T (1999) Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol 9:663\u2013679","DOI":"10.1111\/j.1750-3639.1999.tb00549.x"},{"key":"680_CR42","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/ijms10041872","volume":"10","author":"S Kumar-Singh","year":"2009","unstructured":"Kumar-Singh S (2009) Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models. Int J Mol Sci 10:1872\u20131895. \n                    https:\/\/doi.org\/10.3390\/ijms10041872","journal-title":"Int J Mol Sci"},{"key":"680_CR43","doi-asserted-by":"publisher","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U et al (2012, 1946) Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J 26:\u20131959. \n                    https:\/\/doi.org\/10.1096\/fj.11-199851","DOI":"10.1096\/fj.11-199851"},{"key":"680_CR44","doi-asserted-by":"publisher","unstructured":"Lasagna-Reeves CA, Rousseaux MW, Guerrero-Munoz MJ et al (2015) A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1. Elife 4. \n                    https:\/\/doi.org\/10.7554\/eLife.07558","DOI":"10.7554\/eLife.07558"},{"key":"680_CR45","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1084\/jem.169.5.1771","volume":"169","author":"E Levy","year":"1989","unstructured":"Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B (1989) Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 169:1771\u20131778.","journal-title":"J Exp Med"},{"key":"680_CR46","doi-asserted-by":"publisher","unstructured":"Maphis N, Xu G, Kokiko-Cochran ON et al (2015) Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain 138:1738\u20131755. \n                    https:\/\/doi.org\/10.1093\/brain\/awv081","DOI":"10.1093\/brain\/awv081"},{"key":"680_CR47","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00401-016-1560-2","volume":"131","author":"M Merlini","year":"2016","unstructured":"Merlini M, Wanner D, Nitsch RM (2016) Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy. Acta Neuropathol 131:737\u2013752. \n                    https:\/\/doi.org\/10.1007\/s00401-016-1560-2","journal-title":"Acta Neuropathol"},{"key":"680_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","volume":"70","author":"M Morris","year":"2011","unstructured":"Morris M, Maeda S, Vossel K, Mucke L (2011) The many faces of tau. Neuron 70:410\u2013426. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2011.04.009","journal-title":"Neuron"},{"key":"680_CR49","first-page":"403","volume":"1","author":"K Oshima","year":"2008","unstructured":"Oshima K, Uchikado H, Dickson DW (2008) Perivascular neuritic dystrophy associated with cerebral amyloid angiopathy in Alzheimer's disease. Int J Clin Exp Pathol 1:403\u2013408","journal-title":"Int J Clin Exp Pathol"},{"key":"680_CR50","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.tins.2003.08.006","volume":"26","author":"B Ransom","year":"2003","unstructured":"Ransom B, Behar T, Nedergaard M (2003) New roles for astrocytes (stars at last). Trends Neurosci 26:520\u2013522. \n                    https:\/\/doi.org\/10.1016\/j.tins.2003.08.006","journal-title":"Trends Neurosci"},{"key":"680_CR51","doi-asserted-by":"publisher","unstructured":"Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A (2002) Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A 99: 6364\u20136369. \n                    https:\/\/doi.org\/10.1073\/pnas.092136199","DOI":"10.1073\/pnas.092136199"},{"key":"680_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00401-009-0501-8","volume":"118","author":"T Revesz","year":"2009","unstructured":"Revesz T, Holton JL, Lashley T et al (2009) Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118:115\u2013130. \n                    https:\/\/doi.org\/10.1007\/s00401-009-0501-8","journal-title":"Acta Neuropathol"},{"key":"680_CR53","doi-asserted-by":"publisher","unstructured":"Roberson ED, Halabisky B, Yoo JW et al (2011) Amyloid-beta\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci 31:700\u2013711. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4152-10.2011","DOI":"10.1523\/JNEUROSCI.4152-10.2011"},{"key":"680_CR54","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ et al (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316:750\u2013754. \n                    https:\/\/doi.org\/10.1126\/science.1141736","journal-title":"Science"},{"key":"680_CR55","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682. \n                    https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"key":"680_CR56","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","volume":"78","author":"U Sengupta","year":"2015","unstructured":"Sengupta U, Guerrero-Munoz MJ, Castillo-Carranza DL et al (2015) Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies. Biol Psychiatry 78:672\u2013683. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2014.12.019","journal-title":"Biol Psychiatry"},{"key":"680_CR57","doi-asserted-by":"publisher","unstructured":"Serpente M, Bonsi R, Scarpini E, Galimberti D (2014) Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment. Neuroimmunomodulation 21:79\u201387 \n                    https:\/\/doi.org\/10.1159\/000356529","DOI":"10.1159\/000356529"},{"key":"680_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/13506129.2012.734345","volume":"19","author":"JD Sipe","year":"2012","unstructured":"Sipe JD, Benson MD, Buxbaum JN et al (2012) Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 19:167\u2013170. \n                    https:\/\/doi.org\/10.3109\/13506129.2012.734345","journal-title":"Amyloid"},{"key":"680_CR59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1750-3639.2008.00164.x","volume":"19","author":"R Vidal","year":"2009","unstructured":"Vidal R, Barbeito AG, Miravalle L, Ghetti B (2009) Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2. Brain Pathol 19:58\u201368. \n                    https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00164.x","journal-title":"Brain Pathol"},{"key":"680_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004010051186","volume":"100","author":"R Vidal","year":"2000","unstructured":"Vidal R, Calero M, Piccardo P et al (2000) Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele. Acta Neuropathol 100:1\u201312","journal-title":"Acta Neuropathol"},{"key":"680_CR61","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/21637","volume":"399","author":"R Vidal","year":"1999","unstructured":"Vidal R, Frangione B, Rostagno A et al (1999) A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 399:776\u2013781. \n                    https:\/\/doi.org\/10.1038\/21637","journal-title":"Nature"},{"key":"680_CR62","unstructured":"Vidal R, Garzuly F, Budka H et al (1996) Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G). Am J Pathol 148:361\u2013366"},{"key":"680_CR63","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1073\/pnas.080076097","volume":"97","author":"R Vidal","year":"2000","unstructured":"Vidal R, Revesz T, Rostagno A et al (2000) A decamer duplication in the 3\u2032 region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci U S A 97:4920\u20134925. \n                    https:\/\/doi.org\/10.1073\/pnas.080076097","journal-title":"Proc Natl Acad Sci U S A"},{"key":"680_CR64","doi-asserted-by":"publisher","unstructured":"Viswanathan A, Greenberg SM (2011) Cerebral amyloid angiopathy in the elderly. Ann Neurol 70:871\u2013880. \n                    https:\/\/doi.org\/10.1002\/ana.22516","DOI":"10.1002\/ana.22516"},{"key":"680_CR65","doi-asserted-by":"publisher","unstructured":"Vossel KA, Zhang K, Brodbeck J et al (2010) Tau reduction prevents Abeta-induced defects in axonal transport. Science 330:198. \n                    https:\/\/doi.org\/10.1126\/science.1194653","DOI":"10.1126\/science.1194653"},{"key":"680_CR66","doi-asserted-by":"publisher","unstructured":"Wojtas AM, Kang SS, Olley BM et al (2017) Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Proc Natl Acad Sci U S A 114:E6962-E6971. \n                    https:\/\/doi.org\/10.1073\/pnas.1701137114","DOI":"10.1073\/pnas.1701137114"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0680-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0680-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0680-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T15:12:01Z","timestamp":1589555521000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0680-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0680-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"assertion":[{"value":"29 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mice were housed at the Indiana University School of Medicine (IUSM) animal care facility and were maintained according to USDA standards (12-h light\/dark cycle, food and water ad libitum), in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, Bethesda, MD).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"26"}}